Chargement en cours...
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
The use of targeted agents in the treatment of metastatic colorectal cancer (CRC) has improved patient outcomes. Anti-epidermal growth factor receptor (anti-EGFR) agents (cetuximab and panitumumab) and antiangiogenic molecules (bevacizumab, regorafeninb, ramucirumab, and aflibercept) have been succe...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536012/ https://ncbi.nlm.nih.gov/pubmed/28708103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18071522 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|